Page 22 - 南京医科大学学报自然科学版
P. 22
第42卷第3期
·324 · 南 京 医 科 大 学 学 报 2022年3月
domain targeting peptide antagonizing ErbB2/Neu inhi ⁃ small cell lung cancer cell progression[J]. Cancer Lett,
bits breast tumor growth and metastasis[J]. Cell Rep, 2020,476:129-139
2014,8(6):1714-1721 [19] LIAO Y F,WU Y B,LONG X,et al. High level of BRD4
[12] LI C,ZHANG N,ZHOU J,et al. Peptide blocking of PD⁃1/ promotes non⁃small cell lung cancer progression[J]. On⁃
PD⁃L1 interaction for cancer immunotherapy[J]. Cancer cotarget,2016,7(8):9491-9500
Immunol Res,2018,6(2):178-188 [20] CHEN C Y,JAN CI,LO J F,et al. Tid1⁃L inhibits EGFR
[13] ARPEL A,SAWMA P,SPENLE C,et al. Transmembrane signaling in lung adenocarcinoma by enhancing EGFR
domain targeting peptide antagonizing ErbB2/Neu inhi ⁃ ubiquitinylation and degradation[J]. Cancer Res,2013,
bits breast tumor growth and metastasis[J]. Cell Rep, 73(13):4009-4019
2014,8(6):1714-1721 [21] LING B,LIAO X,HUANG Y,et al. Identification of prog⁃
[14] GATENHOLM B,GOBOM J,SKILLBÄCK T,et al. Pepti⁃ nostic markers of lung cancer through bioinformatics ana⁃
domic analysis of cartilage and subchondral bone in OA lysis and in vitro experiments[J]. Int J Oncol,2020,56
patients[J]. Eur J Clin Invest,2019,49(5):e13082 (1):193-205
[15] SIMO⁃RIUDALBAS L,PEREZ⁃SALVIA M,SETIEN F,et [22] LI C M,HARATIPOUR P,LINGEMAN R G,et al. Novel
al. KAT6B Is a tumor suppressor histone H3 lysine 23 peptide therapeutic approaches for cancer treatment[J].
acetyltransferase undergoing genomic loss in small cell Cells,2021,10(11):2908
lung cancer[J]. Cancer Res,2015,75(18):3936-3945 [23] GREENING D W,KAPP E A,SIMPSON R J. The Pepti⁃
[16] WANG Z,HAN Z,ZHANG L,et al. MicroRNA⁃98⁃5p regu⁃ dome comes of age:mass spectrometry⁃based character⁃
lates the proliferation and apoptosis of A549 cells by tar⁃ ization of the circulating cancer peptidome[J]. Enzymes,
geting MAP4K3[J]. Oncol Lett,2019,18(4):4288-4293 2017,42:27-64
[17] WU X. Up⁃regulation of YPEL1 and YPEL5 and down⁃ [24] CHUANG H C,CHANG C C,TENG C F,et al. MAP4K3/
regulation of ITGA2 in erlotinib⁃treated EGFR⁃mutant non GLK promotes lung cancer metastasis by phosphorylating
⁃ small cell lung cancer:a bioinformatic analysis[J]. and activating IQGAP1[J]. Cancer Res,2019,79(19):
Gene,2018,643:74-82 4978-4993
[18] ZHENG J,ZHANG Y,CAI S,et al. MicroRNA⁃4651 tar⁃ [收稿日期] 2021-11-29
gets bromodomain ⁃ containing protein 4 to inhibit non ⁃ (本文编辑:陈汐敏)